中国三级中心研究:ADNEX模型术前评估卵巢癌风险的外部验证
回顾性单中心大学医院研究纳入282例附件肿块患者,其中良性178例(63.1%)、恶性104例(36.9%),评估ADNEX模型诊断准确性。含CA125时AUC为0.93(95%CI 0.90-0.96),不含CA125时为0.91(95%CI 0.88-0.95),校准图显示预测风险与观察恶性比例一致性良好。结论提示ADNEX模型在中国三级中心外部验证表现良好,有助于附件肿块患者管理。
要点
- 含CA125时ADNEX模型鉴别良恶性AUC为0.93(95%CI 0.90-0.96)
- 不含CA125时AUC为0.91(95%CI 0.88-0.95)
- 校准图显示预测恶性风险与观察恶性比例一致性良好
核心结论
- ADNEX模型在中国三级中心外部验证表现良好,能较好区分肿瘤亚型,作者认为其是临床实践中有价值的工具,可能有助于附件肿块患者管理。
研究设计与样本
- 回顾性单中心大学医院研究,检索335例患者数据、排除53例后纳入282例,全部行经阴道超声检查并测定血清CA125,收集临床病理信息,分别计算含与不含CA125时ADNEX模型的诊断效能。
诊断标准与关键数值
- 含CA125时ADNEX模型鉴别良恶性附件肿块的AUC为0.93(95%CI 0.90-0.96);不含CA125时AUC为0.91(95%CI 0.88-0.95);校准图显示预测恶性风险与观察恶性比例一致性良好。
临床应用与阅片要点
- 作者认为ADNEX模型是临床实践中有价值的工具,可能有助于附件肿块患者管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The Assessment of Different NEoplasias in the adneXa (ADNEX) model was developed by the International Ovarian Tumor Analysis group to assess the risk of an ovarian mass being malignant. This study aimed to externally validate the ADNEX model performance in a tertiary center in China.
METHODS: This retrospective, single-center university hospital study assessed the model diagnostic accuracy. All patients were examined by transvaginal ultrasonography, and serum CA125 levels were measured. Moreover, clinicopathological information was collected. The diagnostic performance of the ADNEX model was calculated with and without CA125 as a predictor.
RESULTS: We retrieved data of 335 patients, of which 53 were excluded based on the exclusion criteria. Of the included 282 patients, 178 (63.1%) had benign tumors, and 104 (36.9%) had malignant tumors. When CA125 was factored in, the area under the receiver operating characteristic curve (AUC) for the distinction between benign and malignant tumors was 0.93 (95% confidence interval [CI], 0.90-0.96), whereas it was 0.91 (95% CI, 0.88-0.95) without CA125. The concordance between the predicted risk of malignancy and the proportion of observed malignancies was well demonstrated by the calibration plots.
CONCLUSIONS: The proper performance of the ADNEX model was verified externally in a tertiary center in China, showing a good distinction between tumour subtypes. Our findings suggest the ADNEX model is a valuable tool in clinical practice and may help in managing patients with adnexal masses.
引用
- Zhang, Zhao, Feng, et al. External Validation of the Assessment of Different NEoplasias in the adneXa Model Performance in Evaluating the Risk of Ovarian Carcinoma Before Surgery in China: A Tertiary Center Study. J Ultrasound Med. 2021. PMID: 34918371. doi:10.1002/jum.15920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。